The Impact of Managed Care on Drug-Dependent Pregnant and Postpartum Women and Their Children

References

• Behnke M., Eyler F. D., Conlon M., Casanova O. Q., Woods N. S. How fetal cocaine exposure increases neonatal hospital costs. Pediatrics 1997; 99(2)204–208
   PubMedGoogle Scholar
• www.cdc.gov/epo/prevent.htm Centers for Disease Control, Accessed on June, 1 2007 from
   Google Scholar
• Center for Substance Abuse Treatment. State methadone treatment guidelines. U.S. Department of Health and Human Services Public Health Service Substance Abuse and Mental Health Services Administration, Rockville, MD 1992, (DHHS Pub. No. SMA 93-1991)
   Google Scholar
• Galanter M., Keller D. S., Dermatis H., Egelko S. The impact of managed care on substance abuse treatment: A report to the American Society of Addiction Medicine. Journal of Addictive Diseases 2000; 19: 13–34
   PubMed Web of Science ®Google Scholar
• Garnick D. W., Hendricks A. M., Comstock C., Horgan C. Do individuals with substance abuse diagnoses incur higher charges than individuals with other chronic conditions?. Journal of Substance Abuse Treatment 1997; 14: 457–465
   PubMed Web of Science ®Google Scholar
• General Accounting Office. Child welfare: Early experiences implementing a managed care approach. Washington, DC 1998, (Report No. GAO-HEHS-99-8)
   Google Scholar
• Hans S. Prenatal drug exposure: Behavioral functioning in late childhood and adolescence. Behavioral studies of drug-exposed offspring: Issues in human and animal research, C. L. Wetherington, V. L. Smerglio, L. P. Finnegan. Research Monograph 164, National Institute on Drug Abuse, Rockville, MD 1996; 261–276
   Google Scholar
• Institute of Medicine. Controlling costs and changing patient care?. National Academy Press, Washington, DC 1989
   Google Scholar
• Institute of Medicine. Managing managed care: Quality improvement in behavioral health. National Academy Press, Washington, DC 1997
   Google Scholar
• Jansson L., Svikis D., Lee J., Paluzzi P., Rutigliano P., Hackerman F. Pregnancy and addiction: A comprehensive care model. Journal of Substance Abuse Treatment 1996; 13: 321–329
   PubMed Web of Science ®Google Scholar
• Jansson L. M., Velez M. Understanding and treating substance users and their infants. Infants and Young Children 1999; 11(4)79–89
   Google Scholar
• Kaltenbach K., Finnegan L. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehavioral Toxicology and Teratology 1986; 8: 353–355
   PubMedGoogle Scholar
• King J. Substance abuse in pregnancy: A bigger problem than you think. Postgraduate Medicine 1997; 102(3)135–150
   PubMed Web of Science ®Google Scholar
• Kirschke D. L., Craig A. S., Schaffner W., Daugherty J. R., Narramore J., Griffen M. R. Childhood immunization rates before and after the implementation of Medicaid managed care. Archives of Pediatric and Adolescent Medicine 2004; 158: 230–235
   PubMedGoogle Scholar
• Langenbucher J. Offsets are not add-ons: the place of addictions treatment in American health care reform. Journal of Addictive Diseases 1994; 6: 117–122
   Google Scholar
• Mayes L. Exposure to cocaine: behavioral outcomes; preschool and school age children. Behavioral studies of drug-exposed offspring: Issues in human and animal research, C. L. Wetherington, V. L. Smerglio, L. P. Finnegan. Research Monograph 164, National Institute on Drug Abuse, Rockville, MD 1996; 211–229
   Google Scholar
• McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1991; 9: 199–213
   Google Scholar
• Mena M., Corvalan S., Bedragal P. Health care expenses among the offspring of cocaine base paste consumers. Revista Medica de Chile 2002; 130: 1241–1248
   PubMedGoogle Scholar
• National Institute on Drug Abuse. National Pregnancy and Health Survey. Drug use among women delivering livebirths: 1992. United States Department of Health and Human Services. 1996, (NIH Publication No. 96-3819)
   Google Scholar
• Olmstead T., White W. D., Sindelar J. The impact of managed care on substance abuse treatment services. Health Services Research 2004; 39(2)319–344
   PubMed Web of Science ®Google Scholar
• Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., et al. Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry 1984; 41: 949–958
   PubMed Web of Science ®Google Scholar
• Rodewald L. E., Szilagyi P. G., Shiuh T., Humiston S. G., LeBaron C., Hall C. B. Is underimmunization a marker for insufficient utilization of preventative and primary care?. Archives of Pediatric and Adolescent Medicine 1995; 149: 393–397
   PubMedGoogle Scholar
• Stichler J. F., Weiss M., Wight N. E. Examining the “cost” of substance abuse in pregnancy: Patient outcomes and resource utilization. Journal of Perinatology 1998; 18: 384–388
   PubMedGoogle Scholar
• Svikis D., Golden A. S., Huggins G. R., Pickens R. W., McCaul M. E., Velez M. L., et al. Cost-effectiveness of drug treatment for pregnant women. Drug and Alcohol Dependence 1997; 45: 105–113
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. The economic costs of alcohol and drug abuse in the United States, 1992. U.S. Government Printing Office, Washington, DC 1998
   Google Scholar
• Warner L. A., Kessler R. C., Hughes M., Anthony J. C., Nelson C. B. Prevalence and correlates of drug use and dependence in the United States; results from the national comorbidity study. Archives of General Psychiatry 1995; 52: 219–229
   PubMed Web of Science ®Google Scholar